| Total Revenue | | 35 |
| Cost of Goods Sold Incl. D&A | | 21 |
| Gross Profit | | 13 |
| Selling, General and Administrative Excl. Other | | 7 |
| Research and Development | | 0 |
| Other Operating Expense | | 1 |
| Operating Income | | 6 |
| Interest Expense | | 12 |
| Unusual Expense | | — |
| Non-Operating Income (Expense) | | -36 |
| Net Income Before Taxes | | 30 |
| Income Taxes | | 9 |
| Consolidated Net Income | | 20 |
| Net Income From Continuing Operations | | 20 |
| Net Income | | 20 |
| EPS (Recurring) | | 0.22 |
| EPS (Basic, Before Extraordinaries) | | 0.22 |
| EPS (Diluted) | | 0.21 |
| EBITDA | | 48 |
| Other After Tax Adjustments | | — |
| Stock Option Compensation Expense | | — |
| Price To Earnings Ratio | | — |
| Price To Sales Ratio | | — |
| Gross Margin | | 37.14 |
| Operating Margin | | 17.14 |
| Net Margin | | 57.14 |
| Shares Outstanding | | 93 |
| Market Capitalization | | — |
| Operating Lease Expense | | — |
